Abstract
Energy homeostasis is regulated by endocrine factors. The concentration of relaxin-3 in serum is related to body mass index. However, relaxin-3 is found only in the brain and testis. In this study, we examined the expression of relaxin- 3 in adipose tissue and its effects on adipogenesis. The expression of relaxin-3 was determined using RT-PCR, a relaxin- 3 C-peptide-specific radioimmunoassay, specifically in the stromal-vascular fraction (SVF) cells rather than adipocytes. The release of C-peptide was regulated by glucose concentration in the SVF cells. However, the differentiated adipocytes did not express relaxin-3. In glucose perfusion experiments, C-peptide was released in response to high glucose concentrations in the mesenteric perfusate, opposite to insulin release. Additionally, GPCR135 mRNA was expressed in adipocytes. Relaxin-3 increased triglycerides in adipocytes and decreased lipase activity. The present study showed that relaxin-3 is secreted from SVF cells and that it regulates lipid accumulation in adipocytes.
Keywords: Adipocyte, GPCR135, lipid accumulation, mesentery adipose tissue, relaxin-3, .
Protein & Peptide Letters
Title:The Expression of Relaxin-3 in Adipose Tissue and its Effects on Adipogenesis
Volume: 21 Issue: 6
Author(s): Hiroyuki Yamamoto, Hiromi Shimokawa, Tatsuomi Haga, Yuki Fukui, Kazuaki Iguchi, Keiko Unno, Minoru Hoshino and Atsushi Takeda
Affiliation:
Keywords: Adipocyte, GPCR135, lipid accumulation, mesentery adipose tissue, relaxin-3, .
Abstract: Energy homeostasis is regulated by endocrine factors. The concentration of relaxin-3 in serum is related to body mass index. However, relaxin-3 is found only in the brain and testis. In this study, we examined the expression of relaxin- 3 in adipose tissue and its effects on adipogenesis. The expression of relaxin-3 was determined using RT-PCR, a relaxin- 3 C-peptide-specific radioimmunoassay, specifically in the stromal-vascular fraction (SVF) cells rather than adipocytes. The release of C-peptide was regulated by glucose concentration in the SVF cells. However, the differentiated adipocytes did not express relaxin-3. In glucose perfusion experiments, C-peptide was released in response to high glucose concentrations in the mesenteric perfusate, opposite to insulin release. Additionally, GPCR135 mRNA was expressed in adipocytes. Relaxin-3 increased triglycerides in adipocytes and decreased lipase activity. The present study showed that relaxin-3 is secreted from SVF cells and that it regulates lipid accumulation in adipocytes.
Export Options
About this article
Cite this article as:
Yamamoto Hiroyuki, Shimokawa Hiromi, Haga Tatsuomi, Fukui Yuki, Iguchi Kazuaki, Unno Keiko, Hoshino Minoru and Takeda Atsushi, The Expression of Relaxin-3 in Adipose Tissue and its Effects on Adipogenesis, Protein & Peptide Letters 2014; 21 (6) . https://dx.doi.org/10.2174/0929866520666131217101424
DOI https://dx.doi.org/10.2174/0929866520666131217101424 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Voltage-Gated Calcium Channels as Targets for the Treatment of Chronic Pain
Current Drug Targets - CNS & Neurological Disorders Alzheimer’s Disease and Autistic Spectrum Disorder: Is there any Association?
CNS & Neurological Disorders - Drug Targets Intracellular Bioinorganic Chemistry and Cross Talk Among Different -Omics
Current Topics in Medicinal Chemistry The Role of Vitamin D in Gastrointestinal Diseases: Inflammation, Gastric Cancer, and Colorectal Cancer
Current Medicinal Chemistry NO to Breast: When, Why and Why Not?
Current Pharmaceutical Design Intraductal Papillary Mucinous Neoplasm (IPMN): A Precursor to Pancreatic Cancer
Current Cancer Therapy Reviews MicroRNAs in Breast Cancer: One More Turn in Regulation
Current Drug Targets Antiproliferative Efficacy of Angiotensin II Receptor Blockers in Prostate Cancer
Current Cancer Drug Targets Eph as a Target in Inflammation
Endocrine, Metabolic & Immune Disorders - Drug Targets Exploring the Technology Landscape of 7TMR Drug Signaling Profiling
Current Topics in Medicinal Chemistry Botulinum Toxin a in Prostate Disease: A Venom from Bench to Bed-Side
Current Drug Delivery Emerging Roles of P2X Receptors in Cancer
Current Medicinal Chemistry Complexity of Gastric Acid Secretion Revealed by Targeted Gene Disruption in Mice
Current Pharmaceutical Design Medical Treatment of Hirsutism in Women
Current Medicinal Chemistry Scheduling of Taxanes: A Review
Current Clinical Pharmacology The Zinc Metallopeptidase Family: New Faces, New Functions
Protein & Peptide Letters The Stomach as an Energy Homeostasis Regulating Center. An Approach for Obesity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Benefits of Olive Oil Phenolic Compounds in Disease Prevention
Endocrine, Metabolic & Immune Disorders - Drug Targets A Review of Premature Frailty in HIV-Infected Persons; Another Manifestation of HIV-Related Accelerated Aging
Current Aging Science Molecular Pathways Associated with Aggressiveness of Papillary Thyroid Cancer
Current Genomics